A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

NCT02010203 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

104

Enrollment

INDUSTRY

Sponsor class

Stopped Inability to accrue due to changing treatment landscape (PD-1 approvals)

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: HS-410
BIOLOGICAL: Placebo
BIOLOGICAL: BCG

Sponsor

Heat Biologics